Rtw Investments, LP Taysha Gene Therapies, Inc. Transaction History
Rtw Investments, LP
- $6.1 Billion
- Q1 2025
A detailed history of Rtw Investments, LP transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 18,787,866 shares of TSHA stock, worth $50 Million. This represents 0.43% of its overall portfolio holdings.
Number of Shares
18,787,866
Previous 8,672,630
116.63%
Holding current value
$50 Million
Previous $15 Million
74.07%
% of portfolio
0.43%
Previous 0.24%
Shares
6 transactions
Others Institutions Holding TSHA
# of Institutions
127Shares Held
151MCall Options Held
70KPut Options Held
4.7K-
Avoro Capital Advisors LLC New York, NY20MShares$53.2 Million0.45% of portfolio
-
Morgan Stanley New York, NY16.8MShares$44.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$31.2 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA10.9MShares$28.9 Million0.31% of portfolio
-
Octagon Capital Advisors LP New York, NY10.7MShares$28.5 Million4.95% of portfolio
About Taysha Gene Therapies, Inc.
- Ticker TSHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,359,500
- Market Cap $129M
- Description
- Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...